A systematic review finds that diagnostic discordance in bone and soft tissue sarcoma may reduce survival, supporting expert second opinions.
International variation in overall survival linked to differences in childhood tumor stage distribution for some cancer types and regions.
Efficacy and Tolerability of a Low-Dose Continuous Regimen of Regorafenib in Refractory Synovial Sarcomas: A Single-Arm, Phase II Trial From India Diagnostic concordance was observed in 296 cases ...
A new case report was published in Oncoscience (Volume 10) on September 20, 2023, entitled, "Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma." Pazopanib, a multi-kinase ...
Researchers from Kyushu University, Japan have developed a novel deep-learning model which can accurately estimate viable tumor cell density from pathological images of osteosarcoma patients, and ...
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY Fig 1. Current metastatic ...
When surgery is part of the treatment plan, choosing a team with deep sarcoma-specific surgical experience is one of the most important decisions a patient can make. With more than 70 distinct sarcoma ...
Discover how OS Therapies' immunotherapy, OST-HER2, originally developed for canine osteosarcoma, shows promising results in fast-tracking treatments for human osteosarcoma. Learn about comparative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results